Q1 2026 Recap: Gastroenterology News and Updates

The first quarter of 2026 delivered a steady stream of meaningful updates in gastroenterology, with advances spanning irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and real-world insights into treatment access and durability. Across clinical trials and observational research, the field continues to move toward more personalized, evidence-driven care while also grappling with persistent gaps in access and affordability.